Immunology

A unique window into 'original antigenic sin'

Our immune systems react most strongly to the viral strains we encountered in our childhoods. Scientists call this original antigenic sin (OAS)—the body's first blush with a virus like influenza or COVID being the "original ...

HIV & AIDS

Experimental mRNA HIV vaccine safe, shows promise in animals

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of ...

Diseases, Conditions, Syndromes

mRNA vaccine yields full protection against malaria in mice

Scientists from the Walter Reed Army Institute of Research and Naval Medical Research Center partnered with researchers at the University of Pennsylvania and Acuitas Therapeutics to develop a novel vaccine based on mRNA technology ...

Diseases, Conditions, Syndromes

Breakthrough in Zika virus vaccine

Researchers from the University of Adelaide have made significant advances in developing a novel vaccine against Zika virus, which could potentially lead to global elimination of the disease.

Diseases, Conditions, Syndromes

FDA approves vaccine for cholera

In a milestone years in the making, a vaccine to prevent cholera, invented and developed by researchers at the University of Maryland School of Medicine's Center for Vaccine Development, was approved today by the U.S. Food ...

page 1 from 3